Summary
69 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 74% a year over the last 3 years.
- It has raised its dividend 12 years in a row and pays out only 29% of profit.
- It holds more cash than debt: $51.1M against $31.4M.
What to watch
- The share price is above the Bulios Fair Price.
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 27.2 USD for 1 USD of yearly profit. Over the last five years it was 20.8 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
Revenue grew by 9.0% a year over 5 years. Over the last 3 years it grew by 12% a year. Earnings per share grew by 74% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 61 USD
- Sales and administration 30 USD
- Taxes and other 0.3 USD
- Net profit 9.0 USD
Net profit, industry median (Medical - Care Facilities) 6.7 USD
Out of every 100 USD of revenue, 9.0 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 1.07%
- Paid out of profit
- 29%
- Raised in a row
- 12 years
You receive $2.62 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Workers' Compensation Insurance 66%
- Professional Liability Insurance 34%
By region
The company reports no revenue by region.
Workers' Compensation Insurance brings in 66% of revenue.
Segments in detail